Industry

Life Sciences Tools & Services

Suppliers of instruments, reagents and contract research for biotech and pharma R&D. Stable demand from growing research budgets; switching costs and proprietary tech provide defensibility.

Total Companies
235
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Thermo Fisher Scientific Inc
NYSE:TMO
Loading...
9% Overvalued
51 / 100
45 / 100
$219B
Danaher Corp
NYSE:DHR
Loading...
15% Overvalued
50 / 100
65 / 100
$163B
Lonza Group AG
SIX:LONN
Loading...
26% Undervalued
48 / 100
53 / 100
$46.4B
Agilent Technologies Inc
NYSE:A
Loading...
1% Overvalued
57 / 100
76 / 100
$39.2B
IQVIA Holdings Inc
NYSE:IQV
Loading...
20% Undervalued
52 / 100
30 / 100
$38.3B
WuXi AppTec Co Ltd
SSE:603259
Loading...
20% Undervalued
61 / 100
77 / 100
$36.9B
Samsung Biologics Co Ltd
KRX:207940
Loading...
Fairly Valued
58 / 100
87 / 100
$30.5B
Mettler-Toledo International Inc
NYSE:MTD
Loading...
25% Overvalued
50 / 100
65 / 100
$28.9B
Sartorius Stedim Biotech SA
PAR:DIM
Loading...
5% Overvalued
47 / 100
48 / 100
$23.6B
Waters Corp
NYSE:WAT
Loading...
18% Overvalued
62 / 100
65 / 100
$22.8B
Illumina Inc
NASDAQ:ILMN
Loading...
2% Overvalued
52 / 100
57 / 100
$20.8B
West Pharmaceutical Services Inc
NYSE:WST
Loading...
19% Overvalued
54 / 100
94 / 100
$20B
Divi's Laboratories Ltd
NSE:DIVISLAB
Loading...
38% Overvalued
55 / 100
99 / 100
$19.3B
WuXi Biologics (Cayman) Inc
HKEX:2269
Loading...
27% Undervalued
53 / 100
96 / 100
$17.1B
Medpace Holdings Inc
NASDAQ:MEDP
Loading...
33% Overvalued
72 / 100
76 / 100
$16B
ICON PLC
NASDAQ:ICLR
Loading...
33% Undervalued
49 / 100
46 / 100
$14B
Eurofins Scientific SE
PAR:ERF
Loading...
32% Undervalued
49 / 100
50 / 100
$13B
T
Tempus AI Inc
NASDAQ:TEM
Loading...
34% Overvalued
33 / 100
46 / 100
$11.5B
R
Revvity Inc
NYSE:RVTY
Loading...
18% Undervalued
47 / 100
50 / 100
$11.1B
W
WuXi XDC Cayman Inc
HKEX:2268
Loading...
4% Overvalued
62 / 100
93 / 100
$10.1B
Load More